# Irinotecan (Camptosar) in Patients With Advanced Sarcomas

> **NCT00509860** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 38 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00509860
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2007-08
- **Final completion:** 2012-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2013-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00509860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00509860, "Irinotecan (Camptosar) in Patients With Advanced Sarcomas". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00509860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*